QIAGEN N.V. to Report First Quarter 2019 Results

QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as previously announced to release its report on results for the first quarter 2019 on Monday, May 6 at approximately 22:05 Central European Time (CET) / 16:05 Eastern Standard Time (EDT). A conference call is planned for Tuesday, May 7 at 15:00 CET / 9:00 EDT hosted by Peer M. Schatz, Chief Executive Officer, and Roland Sackers, Chief Financial Officer.

Conference Call and Webcast Details The conference call will begin at 15:00 CET / 9:00 EDT on Tuesday May 7, 2019.

Interested parties may listen to the call by dialing: +1 929 477 0448 (U.S.), +44 (0)330 336 9125 (UK), +49 (0)69 2222 25574 (Germany). To avoid waiting time, please join the event conference 5-10 minutes prior to the start time. Quoting the following Conference ID: 9120987 to the answering operator.

The webcast will be accessible at: https://globalmeet.webcasts.com/starthere.jsp?ei=1236909&tp_key=fb3cd2e147

A conference call replay will be available by using the following link: https://globalmeet.webcasts.com/starthere.jsp?ei=1236909&tp_key=fb3cd2e147

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

Contact: [email protected]

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December 31, 2018, QIAGEN employed approximately 5,000 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

John Gilardi
Vice President Corporate Communications and Investor
Relations
+49 2103 29 11711
+1 240 686 2222
Email: [email protected]

Phoebe Loh
Associate Director Investor Relations
+49 2103 29
11457
Email: [email protected]